Donald R. Johns
- Clinical Biochemistry top 0.5%
- Metabolism and Genetic Disorders 18
-
- Genetic Neurodegenerative Diseases 6
- Neuroscience and Neuropharmacology Research 3
- Neurology top 2%
- Parkinson's Disease Mechanisms and Treatments 3
- Molecular Biology top 5%
- Mitochondrial Function and Pathology 33
- ATP Synthase and ATPases Research 11
- Cell death mechanisms and regulation 4
- Microbiology top 2%
-
- Drug-Induced Ocular Toxicity 4
- Co-authors
- Maureen TierneyDonna FelsensteinOrest HurkoBaltazar Gomez‐MancillaRachel NardinCharles EilPhilip A. GruppusoPhilip M. Smallwood
- Journals
- New England Journal of Medicine (3 papers)Journal of Biological Chemistry (1 paper)Nature Medicine (2 papers)
- Partner nations
- United StatesSwitzerlandCanada
In The Last Decade
Donald R. Johns
57 papers receiving 3.7k citations
Peers
Comparison fields: 5 of 120
- Clinical Biochemistry 774
- Cellular and Molecular Neuroscience 741
- Neurology 510
- Molecular Biology 2.2k
- Microbiology 190
Countries citing papers authored by Donald R. Johns
This map shows the geographic impact of Donald R. Johns's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donald R. Johns with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donald R. Johns more than expected).
Fields of papers citing papers by Donald R. Johns
This network shows the impact of papers produced by Donald R. Johns. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donald R. Johns. The network helps show where Donald R. Johns may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Donald R. Johns, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 124 | |
| 2 | 2016 | 9 | |
| 3 | 2013 | 35 | |
| 4 | 2011 | 89 | |
| 5 | 2011 | 145 | |
| 6 | 2004 | 37 | |
| 7 | 2004 | 68 | |
| 8 | 2001 | 68 | |
| 9 | 1999 | 25 | |
| 10 | 1998 | 21 | |
| 11 | 1998 | 47 | |
| 12 | 1996 | 66 | |
| 13 | 1996 | 38 | |
| 14 | 1994 | 16 | |
| 15 | 1993 | 52 | |
| 16 | 1991 | 109 | |
| 17 | 1990 | 288 | |
| 18 | 1990 | 18 | |
| 19 | 1989 | 23 | |
| 20 | 1987 | 4 |
About Donald R. Johns
Donald R. Johns is a scholar working on Clinical Biochemistry, Cellular and Molecular Neuroscience and Sensory Systems, having authored 57 papers that have together received 3.8k indexed citations. Recurring topics across this work include Mitochondrial Function and Pathology (33 papers), Metabolism and Genetic Disorders (18 papers), ATP Synthase and ATPases Research (11 papers), Genetic Neurodegenerative Diseases (6 papers), Cell death mechanisms and regulation (4 papers), Drug-Induced Ocular Toxicity (4 papers), Parkinson's Disease Mechanisms and Treatments (3 papers) and Neuroscience and Neuropharmacology Research (3 papers). The work is most often cited by research in Clinical Biochemistry (774 citations), Cellular and Molecular Neuroscience (741 citations) and Neurology (510 citations). Donald R. Johns has collaborated with scholars based in United States, Switzerland and Canada. Frequent co-authors include Maureen Tierney, Donna Felsenstein, Orest Hurko, Baltazar Gomez‐Mancilla, Rachel Nardin, Charles Eil, Philip A. Gruppuso, Philip M. Smallwood, David Valle and Michael A. Levine. Their work appears in journals such as New England Journal of Medicine, Journal of Biological Chemistry and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.